Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001103780-20-000002
Filing Date
2020-05-08
Accepted
2020-05-08 19:05:04
Documents
1
Period of Report
2020-05-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5667
  Complete submission text file 0001103780-20-000002.txt   7147
Mailing Address 1924 BIRKDALE AVE KELOWNA A1 V1P1R7
Business Address
BUNKA CHRISTOPHER (Reporting) CIK: 0001103780 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52138 | Film No.: 20862199

Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Issuer) CIK: 0001348362 (see all company filings)

EIN.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 1000 Metal Mining